JLE

Médecine thérapeutique / Pédiatrie

MENU

The application of magnetic resonance spectroscopy in neuropaediatrics Volume 16, issue 3, Juillet-Août-Septembre 2013

Figures

See all figures

Authors
CHU de Bordeaux, hôpital Pellegrin, service d’imagerie anténatale, de l’enfant et de la femme, place A.-Raba-Léon, 33076 Bordeaux, France, CNRS-université de Bordeaux, CNRS-RMSB, UMR 5536, 33000 Bordeaux, France

Magnetic resonance spectroscopy (MRS) is a technique that complements MRI in the study of brain diseases. Currently, most systems using ≥1.5 T can be used to perform MRS. Following a theoretical overview, the details of modes of acquisition and spectral analysis, in particular, for hydrogen proton spectroscopy, are presented. The main applications are: (1) anoxic-ischaemic injury, particularly in the newborn; (2) degenerative and metabolic diseases; and (3) diagnosis and treatment of brain tumours.